Wealthspire Advisors LLC acquired a new position in Bath & Body Works, Inc. (NYSE:BBWI – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 5,498 shares of the company’s stock, valued at approximately $213,000.
Several other large investors have also recently made changes to their positions in the stock. Fifth Third Wealth Advisors LLC increased its stake in Bath & Body Works by 4.9% during the 4th quarter. Fifth Third Wealth Advisors LLC now owns 6,982 shares of the company’s stock worth $271,000 after buying an additional 324 shares during the period. TD Private Client Wealth LLC increased its stake in Bath & Body Works by 24.2% during the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after buying an additional 331 shares during the period. UMB Bank n.a. increased its position in shares of Bath & Body Works by 58.8% in the 4th quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after purchasing an additional 335 shares during the last quarter. Avior Wealth Management LLC increased its position in shares of Bath & Body Works by 30.3% in the 4th quarter. Avior Wealth Management LLC now owns 1,950 shares of the company’s stock valued at $76,000 after purchasing an additional 453 shares during the last quarter. Finally, Golden State Wealth Management LLC purchased a new stake in shares of Bath & Body Works in the 4th quarter valued at approximately $26,000. 95.14% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of equities research analysts have commented on BBWI shares. Raymond James reissued an “outperform” rating and issued a $46.00 price objective (up from $42.00) on shares of Bath & Body Works in a research report on Tuesday. Piper Sandler increased their price objective on shares of Bath & Body Works from $36.00 to $39.00 and gave the company a “neutral” rating in a research report on Monday, January 6th. Cowen reissued a “buy” rating on shares of Bath & Body Works in a research report on Thursday. Morgan Stanley dropped their price objective on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating on the stock in a research report on Thursday, November 21st. Finally, Argus restated a “hold” rating on shares of Bath & Body Works in a report on Friday, January 10th. Six analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, Bath & Body Works currently has a consensus rating of “Moderate Buy” and an average price target of $44.44.
Bath & Body Works Trading Down 12.5 %
Shares of NYSE:BBWI opened at $35.95 on Friday. The company has a fifty day simple moving average of $37.76 and a 200 day simple moving average of $34.08. The firm has a market cap of $7.79 billion, a PE ratio of 8.77, a price-to-earnings-growth ratio of 0.92 and a beta of 1.83. Bath & Body Works, Inc. has a 12-month low of $26.20 and a 12-month high of $52.99.
Bath & Body Works (NYSE:BBWI – Get Free Report) last released its earnings results on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, beating the consensus estimate of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm had revenue of $2.79 billion during the quarter, compared to analyst estimates of $2.78 billion. As a group, equities research analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.
Bath & Body Works Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, March 7th. Stockholders of record on Friday, February 21st will be issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 2.23%. The ex-dividend date of this dividend is Friday, February 21st. Bath & Body Works’s dividend payout ratio (DPR) is 19.51%.
Bath & Body Works announced that its board has authorized a stock repurchase program on Thursday, February 27th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the company to reacquire up to 6.4% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s leadership believes its stock is undervalued.
Bath & Body Works Profile
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Featured Articles
- Five stocks we like better than Bath & Body Works
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- Financial Services Stocks Investing
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.